Seeking Alpha
 

Denbury Resources Inc. (DNR)

- NYSE
  • Dec. 13, 2013, 4:27 PM
    • Johnson & Johnson (JNJ +0.2%) is said to have received 3 offers of at least $4B each for its Ortho Clinical Diagnostics unit from Danaher (DNR -0.1%), The Carlyle Group (CG +1.6%), and CVC Capital.
    • Previous reports speculated the unit could fetch as much as $5B.
    | 3 Comments
  • Jan. 15, 2013, 7:47 AM
    ConocoPhillips (COP) sells its Cedar Creek Anticline properties to Denbury Resources (DNR) for $1.05B. Comprising about 86K acres in North Dakota/Montana (does not include any Bakken assets), net production averaged 13K barrels of oil equivalent/day in 2012. (PR)
    | 3 Comments
  • Sep. 20, 2012, 8:43 AM
    Denbury Resources (DNR) +9.6% premarket after agreeing to sell its Bakken shale assets in North Dakota and Montana to ExxonMobil (XOM) for $1.6B and XOM's operating interests in Webster Field in Texas and Hartzog Draw Field in Wyoming. The Bakken assets consist of ~196K net acres with expected H2 2012 production of more than 15K boe/day.
    | 2 Comments
Visit Seeking Alpha's
DNR vs. ETF Alternatives
Company Description
Denbury Resources Inc is a domestic oil and natural gas producer in Mississippi and Montana.